基本信息
文件名称:KR019-生命科学试剂-MCE.pdf
文件大小:463.44 KB
总页数:1 页
更新时间:2025-05-24
总字数:约1.75千字
文档摘要
Hotline:400-820-3792
Inhibitors?ScreeningLibraries?Proteins
www.MedChemE
KR019
Cat.No.:HY-173121
分?式:C??H??F?N?O?S
分?量:433.38
作?靶点:HBV
作?通路:Anti-infection
储存?式:Pleasestoretheproductundertherecommendedconditionsin
theCertificateofAnalysis.
BIOLOGICALACTIVITY
?物活性KR019是?种强效的?型肝炎病毒(HBV)?壳组装调节剂,在HBV细胞中表现出强效的抗病毒活性。KR019
能够与核?蛋??聚体-?聚体界?处的疏??袋结合,将?壳组装误导??基因组的?壳中,从?抑制病毒
复制。
REFERENCES
[1].AbbasSA,et,al.Developmentofsulfamoylbenzamide-basedcapsidassemblymodulatorsforhepatitisBviruscapsidassembly.EurJ
MedChem.2025Jun5:290:117430.
McePdfHeight
Caution:Producthasnotbeenfullyvalidatedformedicalapplications.
Forresearchuseonly.
Tel:400-820-3792;021Fax:021E-mail:tech@MedChemE
1/1MasterofBioactiveMolecules—您?边的抑制剂?师